FDA inspection
Avantor Performance Materials Poland S.A.: FDA inspection ending Sep 28, 2022
FDA inspection 1190819 · Voluntary Action Indicated (VAI) · Gliwice
Key facts
| Inspection ID | 1190819 |
|---|---|
| Firm | Avantor Performance Materials Poland S.A. |
| FEI number | 3011558129 |
| Address | Sowinskiego Street 11 |
| City | Gliwice |
| Country | Poland |
| Fiscal year | 2022 |
| Inspection end date | Sep 28, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data